Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
29.83
-1.93 (-6.08%)
Nov 13, 2026, 10:32 AM EST - Market open
Alamar Biosciences Revenue
Alamar Biosciences had revenue of $33.55M in the quarter ending September 30, 2026, with 107.55% growth. This brings the company's total for the last twelve months to $114.05M. In the year 2025, Alamar Biosciences had annual revenue of $74.21M with 195.17% growth. That makes Alamar Biosciences the 21,685th largest company in the world by revenue and 3,203rd in the United States.
Revenue (ttm)
$114.05M
Revenue Growth
+195.17%
P/S Ratio
18.39
Revenue / Employee
$398,783
Employees
286
Market Cap
2.07B
Revenue by Geography
- United States 45.42M 61.2%
- Europe, Middle East and Africa (Excluding Germany) 14.12M 19.0%
- Germany 8.31M 11.2%
- Asia-Pacific 5.82M 7.8%
- Rest of The World 539.00K 0.7%
Fiscal year ended Dec 31, 2025 See the full Alamar Biosciences breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.21M | 49.07M | 195.17% |
| Dec 31, 2024 | 25.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
ALMR News
- 2 days ago - Alamar Biosciences Transcript: UBS Global Healthcare Conference - Transcripts
- 8 days ago - Alamar Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Alamar Biosciences price target raised to $36 from $34 at TD Cowen - TheFly
- 9 days ago - Alamar Biosciences reports Q3 EPS (19c), consensus (19c) - TheFly
- 9 days ago - Alamar Biosciences raises FY26 revenue view to $121M-$123M from $116M-$120M - TheFly
- 9 days ago - Alamar Biosciences partners with GSK on 60,000-sample proteomic study - TheFly
- 9 days ago - Alamar Biosciences Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Alamar Biosciences Earnings release: Q3 2026 - Filings